Literature DB >> 1686905

Lysophosphatidic acids induce contraction of rat isolated colon by two different mechanisms.

A Tokumura1, N Yube, H Fujimoto, H Tsukatani.   

Abstract

Lysophosphatidic acids (1-linoleoyl-, 1-linolenoyl, 1-arachidonoyl- and 1-O-hexadecyl-sn-glycero-3-phosphate) induced rapid contraction of rat isolated colon which was dependent on external Ca2+, 1-linolenoyl-lysophosphatidic acid having the greatest effect. The contraction induced by 1-linolenoyl-lysophosphatidic acid was reduced considerably by nifedipine and verapamil, but not by atropine or indomethacin. Phosphatidic acids with two short-chain acyl groups induced a small, atropine-sensitive contraction at 100 microM, but phosphatidic acids with two long-chain acyl groups were inactive. These results suggest that unlike phosphatidic acids, lysophosphatidic acids act directly on extracellular sites of the plasma membrane of smooth muscle cells in rat colon, mainly through activation of voltage-sensitive Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686905     DOI: 10.1111/j.2042-7158.1991.tb03480.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.

Authors:  Péter Tibor Dancs; Éva Ruisanchez; Andrea Balogh; Cecília Rita Panta; Zsuzsanna Miklós; Rolf M Nüsing; Junken Aoki; Jerold Chun; Stefan Offermanns; Gábor Tigyi; Zoltán Benyó
Journal:  FASEB J       Date:  2017-01-09       Impact factor: 5.191

2.  Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter.

Authors:  Yong Feng; Jun-Feng Liu
Journal:  Exp Ther Med       Date:  2013-12-06       Impact factor: 2.447

3.  A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension.

Authors:  Hiroshi Saga; Akira Ohhata; Akio Hayashi; Makoto Katoh; Tatsuo Maeda; Hirotaka Mizuno; Yuka Takada; Yuka Komichi; Hiroto Ota; Naoya Matsumura; Masami Shibaya; Tetsuya Sugiyama; Shinji Nakade; Katsuya Kishikawa
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 4.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.